General MedicationsINJECTIONGeneric
BROMPHENIRAMINE MALEATE
BROMPHENIRAMINE MALEATE
Standard Dose
100MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview BROMPHENIRAMINE MALEATE is listed in Drugs@FDA under application 083820 (ANDA).
Marketing status: Discontinued Active ingredient BROMPHENIRAMINE MALEATE Form and strength INJECTABLE;INJECTION - 100MG/ML Sponsor WATSON LABS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview BROMPHENIRAMINE MALEATE is listed in Drugs@FDA under application 083820 (ANDA). Marketing status: Discontinued Active ingredient BROMPHENIRAMINE MALEATE Form and strength INJECTABLE;INJECTION - 100MG/ML Sponsor WATSON LABS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.